Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Smart Nano‐PROTACs Reprogram Tumor Microenvironment for Activatable Photo‐metabolic Cancer Immunotherapy
Chi Zhang, Shasha He, Ziling Zeng, et al.
Angewandte Chemie International Edition (2021) Vol. 61, Iss. 8
Closed Access | Times Cited: 100

Showing 26-50 of 100 citing articles:

H2O2-responsive polymer prodrug nanoparticles with glutathione scavenger for enhanced chemo-photodynamic synergistic cancer therapy
Guanchun Wang, Yue Su, Xinliang Chen, et al.
Bioactive Materials (2023) Vol. 25, pp. 189-200
Open Access | Times Cited: 30
Targeted Biomolecule Regulation Platform: A Split-and-Mix PROTAC Approach
Fenfang Yang, Qinhong Luo, Yuechen Wang, et al.
Journal of the American Chemical Society (2023) Vol. 145, Iss. 14, pp. 7879-7887
Closed Access | Times Cited: 26
Carrier-Free Nano-PROTACs to Amplify Photodynamic Therapy Induced DNA Damage through BRD4 Degradation
Linping Zhao, Xiaona Rao, Rongrong Zheng, et al.
Nano Letters (2023) Vol. 23, Iss. 13, pp. 6193-6201
Closed Access | Times Cited: 26
Tumor-targeted PROTAC prodrug nanoplatform enables precise protein degradation and combination cancer therapy
Zhifeng Zou, Lei Yang, Hui-Jun Nie, et al.
Acta Pharmacologica Sinica (2024) Vol. 45, Iss. 8, pp. 1740-1751
Closed Access | Times Cited: 15
Sequential responsive nano-PROTACs for precise intracellular delivery and enhanced degradation efficacy in colorectal cancer therapy
Liuqing Yang, Ye Yang, Jing Zhang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 11
A pH-responsive PROTAC-based nanosystem triggers tumor-specific ferroptosis to construct in situ tumor vaccines
Linghong Huang, Xin‐Yuan Sun, Qinhua Zuo, et al.
Materials Today Bio (2025) Vol. 31, pp. 101523-101523
Open Access | Times Cited: 1
Activable Targeted Protein Degradation Platform Based on Light-triggered Singlet Oxygen
Silong Zhang, Yuanyuan Li, Tao Li, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 4, pp. 3632-3643
Closed Access | Times Cited: 32
Ligation to Scavenging Strategy Enables On-Demand Termination of Targeted Protein Degradation
Yuhui Jin, Jing Fan, Ruyan Wang, et al.
Journal of the American Chemical Society (2023) Vol. 145, Iss. 13, pp. 7218-7229
Closed Access | Times Cited: 22
Cancer-Specific Delivery of Proteolysis-Targeting Chimeras (PROTACs) and Their Application to Cancer Immunotherapy
Yujeong Moon, Seong Ik Jeon, Man Kyu Shim, et al.
Pharmaceutics (2023) Vol. 15, Iss. 2, pp. 411-411
Open Access | Times Cited: 21
Cysteine Cathepsins as Therapeutic Targets in Immune Regulation and Immune Disorders
Emanuela Senjor, Janko Kos, Milica Perišić Nanut
Biomedicines (2023) Vol. 11, Iss. 2, pp. 476-476
Open Access | Times Cited: 21
Tumor Metabolism-Rewriting Nanomedicines for Cancer Immunotherapy
Xiao Dong, Xia Shu, Shubo Du, et al.
ACS Central Science (2023) Vol. 9, Iss. 10, pp. 1864-1893
Open Access | Times Cited: 20
The application of nanoparticles in immunotherapy for hepatocellular carcinoma
Xinyao Hu, Hua Zhu, Xiaoqin He, et al.
Journal of Controlled Release (2023) Vol. 355, pp. 85-108
Closed Access | Times Cited: 19
Advancements in the Application of the Fenton Reaction in the Cancer Microenvironment
Rile Ou, Gerile Aodeng, Jun Ai
Pharmaceutics (2023) Vol. 15, Iss. 9, pp. 2337-2337
Open Access | Times Cited: 18
Nanoliposomal Bcl-xL proteolysis-targeting chimera enhances anti-cancer effects on cervical and breast cancer without on-target toxicities
Jiaming Zhang, Baofang Zhang, Congli Pu, et al.
Advanced Composites and Hybrid Materials (2023) Vol. 6, Iss. 2
Closed Access | Times Cited: 17
Dual‐Programmable Semiconducting Polymer NanoPROTACs for Deep‐Tissue Sonodynamic‐Ferroptosis Activatable Immunotherapy
Fengshuo Wang, Guoqiang Dong, Mengbin Ding, et al.
Small (2023) Vol. 20, Iss. 8
Closed Access | Times Cited: 17
High‐Throughput Miniaturized Synthesis of PROTAC‐Like Molecules
Ye Tian, Maximilian Seifermann, Liana Bauer, et al.
Small (2024) Vol. 20, Iss. 26
Closed Access | Times Cited: 6
Application of PROTACs in target identification and validation
Yang Liu, Jing Liang, Rui Zhu, et al.
Acta Materia Medica (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 6
Phototherapeutic nanoagents for cancer immunotherapy
Maomao He, M. Xiao, Ran Wang, et al.
Progress in Materials Science (2024) Vol. 147, pp. 101347-101347
Closed Access | Times Cited: 6
Proteolysis-targeting drug delivery system (ProDDS): integrating targeted protein degradation concepts into formulation design
Yu Chen, Fengyuan Liu, Samira Pal, et al.
Chemical Society Reviews (2024) Vol. 53, Iss. 19, pp. 9582-9608
Closed Access | Times Cited: 6
Self‐Splittable Transcytosis Nanoraspberry for NIR‐II Photo‐Immunometabolic Cancer Therapy in Deep Tumor Tissue
Li Wang, Wei Jiang, Yanhong Su, et al.
Advanced Science (2022) Vol. 9, Iss. 32
Open Access | Times Cited: 25
Activating Nanomedicines with Electromagnetic Energy for Deep‐Tissue Induction of Immunogenic Cell Death in Cancer Immunotherapy
Fengshuo Wang, Kanyi Pu, Jingchao Li
Small Methods (2022) Vol. 7, Iss. 5
Closed Access | Times Cited: 24
Targeted Protein Degradation Technology and Nanomedicine: Powerful Allies against Cancer
Jiayi Lin, Haijun Liu, Ye Wu, et al.
Small (2023) Vol. 19, Iss. 18
Closed Access | Times Cited: 16
Conjugated Polymer Nanoparticles for Tumor Theranostics
Tianyu Li, Mengqi Wu, Qidong Wei, et al.
Biomacromolecules (2023) Vol. 24, Iss. 5, pp. 1943-1979
Closed Access | Times Cited: 15
Tailoring albumin-based theranostic PROTACs nanoparticles for enhanced NIR-II bioimaging and synergistic cancer chemo-phototherapy
Zhuang Hu, Ruihan Li, Xinyue Cui, et al.
Chemical Engineering Journal (2023) Vol. 469, pp. 143883-143883
Closed Access | Times Cited: 14
Beyond canonical PROTAC: biological targeted protein degradation (bioTPD)
Huifang Wang, Runhua Zhou, Fushan Xu, et al.
Biomaterials Research (2023) Vol. 27, Iss. 1
Open Access | Times Cited: 14

Scroll to top